Research


FDA fast-tracked more MIT-born biotechs than industry average, study finds

Pandemic economics: The economy of fear

Helping Companies Prioritize Their Cybersecurity Investments

Will The Coronavirus Help mRNA And DNA Vaccines Prove Their Worth?

Renaissance Says Quant Models Misfired During March Mayhem

Coronavirus Stokes $200 Billion Stock Market Bubble In Vaccines

Even The Best AI Models Are No Match For The Coronavirus

A COVID-19 Vaccine At What Price? Should All Americans Be Able To Get A Shot For Free?

The Stock Market Will Be Flying High in a Year — For 2 Simple Reasons

With Donations Down, Nonprofits Need to Do a Better Job of Managing Their Endowments